{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T20:56:17Z","timestamp":1778705777499,"version":"3.51.4"},"reference-count":50,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,7,27]],"date-time":"2012-07-27T00:00:00Z","timestamp":1343347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000054","name":"The National Cancer Institute","doi-asserted-by":"crossref","award":["U24 CA 55727"],"award-info":[{"award-number":["U24 CA 55727"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Cancer Center Support","award":["CA21765"],"award-info":[{"award-number":["CA21765"]}]},{"DOI":"10.13039\/100012524","name":"The American Lebanese-Syrian Associated Charities","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2013,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Adult survivors of childhood cancer are at risk for long\u2010term morbidities, which may be managed pharmacologically. Psychoactive medication treatment has been associated with adverse effects on specific neurocognitive processes in non\u2010cancer populations, yet these associations have not been examined in adult survivors of childhood cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Procedure<\/jats:title><jats:p>Outcomes were evaluated in 7,080 adult survivors from the Childhood Cancer Survivor Study (CCSS) using a validated self\u2010report Neurocognitive Questionnaire. Multivariable logistic regression models were used to calculate odds ratios (OR) and 95% confidence intervals (CI) for neurocognitive impairment using demographic and treatment factors and survivors' report of prescription medication use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Controlling for cranial radiation, pain, psychological distress, and stroke\/seizure, use of antidepressant medications was associated with impaired task efficiency (OR\u2009=\u20091.80, 95% CI\u2009=\u20091.47\u20132.21), organization (OR\u2009=\u20091.83, 95% CI\u2009=\u20091.48\u20132.25), memory (OR\u2009=\u20091.53, 95% CI\u2009=\u20091.27\u20131.84), and emotional regulation (OR\u2009=\u20092.06, 95% CI\u2009=\u20091.70\u20132.51). Neuroleptics and stimulants were associated with impaired task efficiency (OR\u2009=\u20092.46, 95% CI\u2009=\u20091.29\u20134.69; OR\u2009=\u20092.82, 95% CI\u2009=\u20091.61\u20134.93, respectively) and memory (OR\u2009=\u20092.08, 95% CI\u2009=\u20091.13\u20133.82; OR\u2009=\u20092.69, 95% CI\u2009=\u20091.59\u20134.54, respectively). Anticonvulsants were associated with impaired task efficiency, memory, and emotional regulation, although survivors who use these medications may be at risk for neurocognitive impairment on the basis of seizure disorder and\/or underlying tumor location (CNS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These findings suggest that specific psychoactive medications and\/or mental health conditions may be associated with neurocognitive function in adult survivors of childhood cancer. The extent to which these associations are causal or indicative of underlying neurological impairment for which the medications are prescribed remains to be ascertained. Pediatr Blood Cancer 2013; 60: 486\u2013493. \u00a9 2012 Wiley Periodicals, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pbc.24255","type":"journal-article","created":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T07:22:37Z","timestamp":1343460157000},"page":"486-493","source":"Crossref","is-referenced-by-count":23,"title":["Psychoactive medication use and neurocognitive function in adult survivors of childhood cancer: A report from the childhood cancer survivor study"],"prefix":"10.1002","volume":"60","author":[{"given":"Tara M.","family":"Brinkman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole J.","family":"Ullrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pim","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel M.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deo Kumar","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lonnie K.","family":"Zeltzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn","family":"Stovall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie L.","family":"Robison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin R.","family":"Krull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,27]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa060185"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.12.1583"},{"key":"e_1_2_6_4_2","unstructured":"BrinkmanTM UllrichNJ ZhangN et al. Prevalence and predictors of prescription psychoactive medication use in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Manuscript submitted."},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1037\/a0016674"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0147-0272(03)00026-6"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-004-3009-z"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.05.186"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200005000-00004"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-186502"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.23060"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jpepsy\/jsj019"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11355"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1037\/0894-4105.22.2.159"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.03.001"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2007.08.123"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1116-0"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0149-7634(94)00068-C"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/026988110201600303"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/026988110101500304"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000063308.22506.19"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318206ca02"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.18.2.217"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.1813"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.1316"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.3339"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23809"},{"key":"e_1_2_6_28_2","unstructured":"American Society of Health\u2010System Pharmacists. AHFS Drug Information. Available from:http:\/\/www.ahfsdruginformation.com\/. Accessed June 10 2011."},{"key":"e_1_2_6_29_2","volume-title":"Brief Symptom Inventory (BSI): Administration, scoring, and procedures manual","author":"Derogatis L","year":"2000"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq156"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000165994.46777.BE"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1995.tb04468.x"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199806000-00006"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881105048887"},{"key":"e_1_2_6_35_2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1176\/jnp.13.3.385","article-title":"Impairments of attention and effort among patients with major affective disorders","volume":"13","author":"Cohen R","year":"2001","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.15.1.98"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(04)01507-4"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(04)00906-8"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0193-953X(02)00084-9"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2004.00111.x"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1586\/ern.09.143"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890423349"},{"key":"e_1_2_6_43_2","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.6004\/jnccn.2007.0089","article-title":"Update on psychotropic medications for cancer\u2010related fatigue","volume":"5","author":"Breitbart W","year":"2007","journal-title":"J Natl Compr Canc Netw"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/PSY.0b013e31817b9793"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25797"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.07.047"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2010.03.006"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-003-1457-3"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/jclp.1030"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20230"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1097\/WNN.0b013e3181c5e2d4"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.24255","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.24255","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.24255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T19:13:08Z","timestamp":1697656388000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.24255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,27]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.1002\/pbc.24255"],"URL":"https:\/\/doi.org\/10.1002\/pbc.24255","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,27]]}}}